Shield Therapeutics plc (SHIEF) Financials
SHIEF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 53.6 million | 70.6 million |
| Dec. 31, 2025 | 65.3 million | 80.4 million |
| June 30, 2025 | 62.1 million | 77.0 million |
| Dec. 31, 2024 | 57.5 million | 58.8 million |
SHIEF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | 707605 | ? |
| Dec. 31, 2025 | -13.0 million | ? |
| June 30, 2025 | 8.2 million | 364364 |
| Dec. 31, 2024 | -1.5 million | 129137 |
SHIEF Net Income
No data available :(
SHIEF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 8.3 million | 24.9 million | - |
| Dec. 31, 2025 | 11.6 million | 30.2 million | - |
| June 30, 2025 | 10.8 million | 26.9 million | 99000 |
| Dec. 31, 2024 | 6.5 million | 26.2 million | 196000 |
SHIEF Shares Outstanding
SHIEF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 27601 | 922457 | 16.3 million | - |
| Dec. 31, 2025 | 24150 | 802820 | 15.6 million | - |
| June 30, 2025 | 3 | 1.1 million | 15.5 million | - |
| Dec. 31, 2024 | 466 | 683588 | 8.0 million | - |
SHIEF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 29.9 million | 12.6 million |
| Dec. 31, 2025 | 28.4 million | 16.3 million |
| June 30, 2025 | 21.3 million | 10.8 million |
| Dec. 31, 2024 | 9.4 million | 4.9 million |
SHIEF
Price: $0.07
52 week price:
Earnings Per Share: -0.02 USD
P/E Ratio: -7.06
Exchange: OQB
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 91.6 million